In our prior preclinical study addressing technical aspects and involving 100 bladder cancer patients and 108 controls with and without hematuria, we identified hypermethylation of GHSR/MAL as urinary biomarkers with good diagnostic potential. Here, GHSR is linked to urinary bladder carcinoma.